3rd Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); Drug safety issues; Prescription drug abuse; H.R. 6, 21st Century Cures Act; H.R. 2841, FAST Generics Act

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), H.R. 2841 (114th)

Pharmacy PHA

S. 3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES Act of 2016)

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3056 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.